← Every company
Cytokinetics Inc Planned Sales
Before an insider at Cytokinetics Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
CYTK insider trades →Notices on file
2
Insiders
2
Shares noticed
99.9K
permission to sell, not sales
Estimated value
$7.2M
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| I. Blum RobertPresident, CEO, Director2026-09-1597.9K sh0.07% | $7.1M |
| Landry RobertDirector2026-09-112K sh<0.01% | $147.2K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on CYTK
Company overviewEverything on CYTK in one place, with the price.SEC filingsWhat CYTK's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat CYTK's own officers and directors buy and sell.Executive payWhat CYTK awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in CYTK.Funds holding itWhich funds and ETFs hold CYTK, and how big a bet.LobbyingWhat CYTK spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on CYTK's account, and who they worked for.PatentsWhat CYTK is filing at the patent office.